Here are four observations:
1. MACI is intended for the treatment of focal chondral cartilage defects in the knee.
2. MACI — matrix-applied characterized autologous cultured chondrocytes — is a third-generation autologous chondrocyte implantation product.
3. MACI was the first tissue-engineered product approved under the advanced therapy medicinal product guidelines by the European Commission.
4. Vericel is a developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions.
More articles on devices:
Blue Belt Technologies’s STRIDE knee system used in 1k procedures — 5 quick facts
Integra LifeSciences, Smith & Newphew, NuVasive & more — 14 key notes
Smith & Nephew voluntarily removes BIRMINGHAM HIP Resurfacing System components: 5 things to know
